SENTI BIOSCIENCES INC (SNTI) Fundamental Analysis & Valuation

NASDAQ:SNTI • US81726A2096

Current stock price

0.812 USD
+0.04 (+5.21%)
At close:
0.84 USD
+0.03 (+3.45%)
Pre-Market:

This SNTI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. SNTI Profitability Analysis

1.1 Basic Checks

  • In the past year SNTI has reported negative net income.
  • In the past year SNTI has reported a negative cash flow from operations.
  • In the past 5 years SNTI always reported negative net income.
  • SNTI had a negative operating cash flow in each of the past 5 years.
SNTI Yearly Net Income VS EBIT VS OCF VS FCFSNTI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

  • The Return On Assets of SNTI (-90.31%) is worse than 72.34% of its industry peers.
  • The Return On Equity of SNTI (-585.90%) is worse than 77.18% of its industry peers.
Industry RankSector Rank
ROA -90.31%
ROE -585.9%
ROIC N/A
ROA(3y)-48.54%
ROA(5y)-48.78%
ROE(3y)-85.31%
ROE(5y)-82.35%
ROIC(3y)N/A
ROIC(5y)N/A
SNTI Yearly ROA, ROE, ROICSNTI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

  • SNTI does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SNTI Yearly Profit, Operating, Gross MarginsSNTI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 -5K -10K -15K -20K -25K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. SNTI Health Analysis

2.1 Basic Checks

  • SNTI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SNTI has been increased compared to 1 year ago.
  • Compared to 5 years ago, SNTI has more shares outstanding
  • SNTI has a worse debt/assets ratio than last year.
SNTI Yearly Shares OutstandingSNTI Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M
SNTI Yearly Total Debt VS Total AssetsSNTI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

  • Based on the Altman-Z score of -12.87, we must say that SNTI is in the distress zone and has some risk of bankruptcy.
  • SNTI's Altman-Z score of -12.87 is on the low side compared to the rest of the industry. SNTI is outperformed by 77.95% of its industry peers.
  • There is no outstanding debt for SNTI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -12.87
ROIC/WACCN/A
WACC9.28%
SNTI Yearly LT Debt VS Equity VS FCFSNTI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

  • A Current Ratio of 1.51 indicates that SNTI should not have too much problems paying its short term obligations.
  • SNTI has a worse Current ratio (1.51) than 82.59% of its industry peers.
  • A Quick Ratio of 1.51 indicates that SNTI should not have too much problems paying its short term obligations.
  • The Quick ratio of SNTI (1.51) is worse than 80.66% of its industry peers.
Industry RankSector Rank
Current Ratio 1.51
Quick Ratio 1.51
SNTI Yearly Current Assets VS Current LiabilitesSNTI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SNTI Growth Analysis

3.1 Past

  • SNTI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 82.10%, which is quite impressive.
  • Looking at the last year, SNTI shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)82.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.06%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 13.52% on average over the next years. This is quite good.
  • Based on estimates for the next years, SNTI will show a very strong growth in Revenue. The Revenue will grow by 73.65% on average per year.
EPS Next Y81.81%
EPS Next 2Y37.96%
EPS Next 3Y23.63%
EPS Next 5Y13.52%
Revenue Next Year-76.19%
Revenue Next 2Y-22.85%
Revenue Next 3Y-25.99%
Revenue Next 5Y73.65%

3.3 Evolution

SNTI Yearly Revenue VS EstimatesSNTI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2028 2029 2030 2031 2032 2033 100M 200M 300M
SNTI Yearly EPS VS EstimatesSNTI Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -5 -10 -15

More info and screens

Find the best growth stocksShow best growing peers

1

4. SNTI Valuation Analysis

4.1 Price/Earnings Ratio

  • SNTI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year SNTI is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SNTI Price Earnings VS Forward Price EarningsSNTI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SNTI Per share dataSNTI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

  • A more expensive valuation may be justified as SNTI's earnings are expected to grow with 23.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.96%
EPS Next 3Y23.63%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. SNTI Dividend Analysis

5.1 Amount

  • No dividends for SNTI!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

SNTI Fundamentals: All Metrics, Ratios and Statistics

SENTI BIOSCIENCES INC

NASDAQ:SNTI (3/31/2026, 8:07:37 PM)

Premarket: 0.84 +0.03 (+3.45%)

0.812

+0.04 (+5.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-18
Earnings (Next)N/A
Inst Owners21.35%
Inst Owner Change-4.25%
Ins Owners0.83%
Ins Owner Change-0.02%
Market Cap21.35M
Revenue(TTM)N/A
Net Income(TTM)-47.58M
Analysts84
Price Target11.73 (1344.58%)
Short Float %6.55%
Short Ratio4.18
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.81%
Min EPS beat(2)-19.38%
Max EPS beat(2)39%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 2.63
P/tB 2.63
EV/EBITDA N/A
EPS(TTM)-2.79
EYN/A
EPS(NY)-1.44
Fwd EYN/A
FCF(TTM)-1.91
FCFYN/A
OCF(TTM)-1.9
OCFYN/A
SpS0
BVpS0.31
TBVpS0.31
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -90.31%
ROE -585.9%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-48.54%
ROA(5y)-48.78%
ROE(3y)-85.31%
ROE(5y)-82.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.62%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.51
Quick Ratio 1.51
Altman-Z -12.87
F-Score4
WACC9.28%
ROIC/WACCN/A
Cap/Depr(3y)1099.41%
Cap/Depr(5y)844.98%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)82.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.06%
EPS Next Y81.81%
EPS Next 2Y37.96%
EPS Next 3Y23.63%
EPS Next 5Y13.52%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-76.19%
Revenue Next 2Y-22.85%
Revenue Next 3Y-25.99%
Revenue Next 5Y73.65%
EBIT growth 1Y-5.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year4.76%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y32.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y7.89%
OCF growth 3YN/A
OCF growth 5YN/A

SENTI BIOSCIENCES INC / SNTI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SENTI BIOSCIENCES INC (SNTI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to SNTI.


What is the valuation status for SNTI stock?

ChartMill assigns a valuation rating of 1 / 10 to SENTI BIOSCIENCES INC (SNTI). This can be considered as Overvalued.


What is the profitability of SNTI stock?

SENTI BIOSCIENCES INC (SNTI) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for SNTI stock?

The Earnings per Share (EPS) of SENTI BIOSCIENCES INC (SNTI) is expected to grow by 81.81% in the next year.